Valuation: Divi's Laboratories Limited

Market Cap 2,224B 23.38B 20.3B 18.93B 17.39B 32.89B 33.25B 223B 87.24B 1,112B 87.8B 85.88B 3,684B P/E 2027 *
68.8x
P/E 2028 * 57.3x
Enterprise Value 2,189B 23.01B 19.98B 18.63B 17.12B 32.37B 32.73B 220B 85.87B 1,094B 86.42B 84.53B 3,626B EV / Sales 2027 *
17.5x
EV / Sales 2028 * 14.6x
Free-Float
48%
Yield 2027 *
0.42%
Yield 2028 * 0.49%
1 day-2.41%
1 week+13.00%
Current month+4.00%
1 month+23.99%
3 months+28.84%
6 months+34.93%
Current year+31.06%
1 week 7,428.5
Extreme 7428.5
8,585
1 month 6,693
Extreme 6693
8,585
Current year 5,647.5
Extreme 5647.5
8,585
1 year 5,636.5
Extreme 5636.5
8,585
3 years 3,295.3
Extreme 3295.3
8,585
5 years 2,730
Extreme 2730
8,585
10 years 532.65
Extreme 532.65
8,585
Manager TitleAgeSince
Chief Executive Officer 75 26/11/2009
Chief Executive Officer 48 04/01/2020
Director of Finance/CFO 65 01/08/2025
Director TitleAgeSince
Director/Board Member 48 26/11/2009
Chairman 75 26/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap.
26/3/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/3/25 Sell 300 0.0001%
17/2/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-2.41%+13.00%+31.70%+124.83% 23.91B
-0.36%-8.44%+45.34%+148.66% 1T
-0.18%-4.80%+48.46%+50.21% 613B
-0.74%-7.64%+23.27%+64.54% 433B
+0.48%-2.77%+40.27%+34.96% 350B
+0.08%-4.45%+31.74%+39.89% 292B
+2.09%-9.27%+5.42%+7.61% 239B
+1.75%-8.29%-1.73%-42.05% 206B
+2.48%-1.19%+28.64%+59.66% 204B
+0.31%-2.13%+14.80%+67.08% 163B
Average +0.37%-1.91%+26.79%+55.54% 352.44B
Weighted average by Cap. +0.21%-4.20%+33.61%+71.09%

Financials

2027 *2028 *
Net sales 125B 1.31B 1.14B 1.06B 978M 1.85B 1.87B 12.55B 4.91B 62.53B 4.94B 4.83B 207B 149B 1.57B 1.36B 1.27B 1.16B 2.2B 2.23B 14.95B 5.84B 74.46B 5.88B 5.75B 247B
Net income 32.35B 340M 295M 275M 253M 478M 484M 3.25B 1.27B 16.17B 1.28B 1.25B 53.59B 38.89B 409M 355M 331M 304M 575M 581M 3.9B 1.53B 19.44B 1.54B 1.5B 64.41B
Net Debt -35B -368M -319M -298M -274M -518M -523M -3.51B -1.37B -17.5B -1.38B -1.35B -57.97B -44.85B -472M -409M -382M -351M -663M -671M -4.5B -1.76B -22.42B -1.77B -1.73B -74.29B
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
04/08/26 INR 8,378.00 -2.41% 970,329
03/08/26 INR 8,585.00 +6.57% 1,798,150
31/07/26 INR 8,056.00 +2.82% 793,919
30/07/26 INR 7,835.00 +0.65% 651,446
29/07/26 INR 7,784.50 +4.84% 1,158,131
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
30
Last Close Price
8,378.00INR
Average target price
8,061.70INR
Spread / Average Target
-3.78%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock